Labofine moves its laboratory to Pointe-Claire

(PresseBox) ( Pointe-Claire, Québec, )
Labofine is proud to announce the grand opening of a new 60,000 square feet facility in Pointe-Claire, Quebec. Labofine has moved its current operations in Laval to this new location, located at 5600 Trans-Canada Hwy, Pointe-Claire, QC H9R 1B6, Canada.

Since its foundation, Labofine has committed to be one-step ahead in terms of testing innovation and quality control of supplements, pharmaceuticals, cosmetics and food products. Today, being part of the Tentamus Group, this location will allow the expansion of a strategy incorporated within the culture of Labofine.

"Our new state-of-the-art facility is a proof of Tentamus commitment to building an impressive footprint in Canada to support the testing needs of our partners across North America. This location has an abundance of Laboratory space, that will accommodate our growth for the upcoming ten years" said Dr. Sam Sammane, CEO of Labofine. This major laboratory expansion will also allow the addition of state-of-the-art equipment in order to support our customers and develop more advanced methods to accommodate their needs.

ABOUT Labofine

Labofine first entered the Canadian testing market in 2014 with the opening of its Laval, Quebec location. Since then, it has seen tremendous growth, including the opening of operations in California in 2017 to offer an extensive coverage of the North American market. After joining the Tentamus Group in 2019, Labofine continues to expand its reach to better serve its Canadian customers in the domain of supplements, pharmaceuticals, cosmetics and food products.

 Source : Labofine Headquarters
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to